98 related articles for article (PubMed ID: 19642098)
1. Extraribosomal function of metallopanstimulin-1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth.
Dai Y; Pierson SE; Dudney WC; Stack BC
Int J Cancer; 2010 Feb; 126(3):611-9. PubMed ID: 19642098
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal protein metallopanstimulin-1 impairs multiple myeloma CAG cells growth and inhibits fibroblast growth factor receptor 3.
Dai Y; Pierson S; Dudney C; Zeng Y; Macleod V; Shaughnessy JD; Stack BC
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):490-7. PubMed ID: 21889435
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity.
Wang YW; Qu Y; Li JF; Chen XH; Liu BY; Gu QL; Zhu ZG
Clin Cancer Res; 2006 Aug; 12(16):4965-73. PubMed ID: 16914586
[TBL] [Abstract][Full Text] [Related]
4. Conservation of multifunctional ribosomal protein metallopanstimulin-1 (RPS27) through complex evolution demonstrates its key role in growth regulation in Archaea, eukaryotic cells, DNA repair, translation and viral replication.
Fernandez-Pol JA
Cancer Genomics Proteomics; 2011; 8(3):105-26. PubMed ID: 21518817
[TBL] [Abstract][Full Text] [Related]
5. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: immunohistochemical and serological correlation with FDG positron emission tomography.
Stack BC; Dalsaso TA; Lee C; Lowe VJ; Hamilton PD; Fletcher JW; Fernandez-Pol JA
Anticancer Res; 1999; 19(6C):5503-10. PubMed ID: 10697607
[TBL] [Abstract][Full Text] [Related]
7. A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin.
Lee WJ; Keefer K; Hollenbeak CS; Stack BC
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):466-71. PubMed ID: 15467619
[TBL] [Abstract][Full Text] [Related]
8. Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4.
Yang ZY; Jiang H; Qu Y; Wei M; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Carcinogenesis; 2013 Dec; 34(12):2851-60. PubMed ID: 23803695
[TBL] [Abstract][Full Text] [Related]
9. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
Flinterman M; Gäken J; Farzaneh F; Tavassoli M
Oncogene; 2003 Apr; 22(13):1965-77. PubMed ID: 12673202
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of metallopanstimulin-1 inhibits NF-κB signaling at different levels: the role of apoptosis induction of gastric cancer cells.
Yang ZY; Qu Y; Zhang Q; Wei M; Liu CX; Chen XH; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Int J Cancer; 2012 Jun; 130(12):2761-70. PubMed ID: 21796632
[TBL] [Abstract][Full Text] [Related]
11. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia.
Ganger DR; Hamilton PD; Klos DJ; Jakate S; McChesney L; Fernandez-Pol JA
Cancer Detect Prev; 2001; 25(3):231-6. PubMed ID: 11425264
[TBL] [Abstract][Full Text] [Related]
14. Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma.
Fernandez-Pol JA; Fletcher JW; Hamilton PD; Klos DJ
Anticancer Res; 1997; 17(3A):1519-30. PubMed ID: 9179190
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
16. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
Masuda M; Ruan HY; Ito A; Nakashima T; Toh S; Wakasaki T; Yasumatsu R; Kutratomi Y; Komune S; Weinstein IB
Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
Wan H; Oridate N; Lotan D; Hong WK; Lotan R
Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
[TBL] [Abstract][Full Text] [Related]
18. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
20. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
Bran G; Götte K; Riedel K; Hörmann K; Riedel F
In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]